ifosfamide has been researched along with azomycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, SK; Wallen, CA; Wheeler, KT | 1 |
| Lü, HX; Pang, H; Wang, WQ; Zhang, ZH; Zhou, JP | 1 |
| Ahluwalia, D; Ferraro, DJ; Hart, CP; Jung, D; Liu, Q; Matteucci, MD; Sun, JD; Wang, Y | 1 |
1 review(s) available for ifosfamide and azomycin
| Article | Year |
|---|---|
[An overview of glycoconjugates for cancer targeting therapy and diagnosis].
Topics: Animals; Antineoplastic Agents; Drug Carriers; Energy Metabolism; Glucose; Glycoconjugates; Glycolysis; Glycosides; Humans; Ifosfamide; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents | 2013 |
1 trial(s) available for ifosfamide and azomycin
| Article | Year |
|---|---|
Comparison of hypoxia-activated prodrug evofosfamide (TH-302) and ifosfamide in preclinical non-small cell lung cancer models.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Humans; Ifosfamide; Lung Neoplasms; Mice; Nitroimidazoles; Phosphoramide Mustards; Prodrugs; Xenograft Model Antitumor Assays | 2016 |
1 other study(ies) available for ifosfamide and azomycin
| Article | Year |
|---|---|
Modification of alkylating agent induced cell kill by 2-nitroimidazoles in unclamped and clamped SC 9L tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cell Survival; Cyclophosphamide; Etanidazole; Ifosfamide; Male; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Rats; Rats, Inbred F344 | 1992 |